Skip to main content

Want a detailed portfolio tracker?

Y-Mabs Therapeutics (YMAB) Profit Margin (2021 - 2025)

Y-Mabs Therapeutics (YMAB) profit margin from Mar 31, 2021 to Jun 30, 2025. The current Y-Mabs Therapeutics (YMAB) profit margin is -16.60%. You can export chart.

Annual Profit Margin

Quarterly Profit Margin

Annual Profit Margin change of Y-Mabs Therapeutics (YMAB)

YearProfit MarginChange
2024-33.84%
+33.92%
2023-25.27%
-82.74%
2022-146.42%
-7.54%
2021-158.37%
-72.46%
2020-575.13%
N/A

Comparison Y-Mabs Therapeutics (YMAB) profit margin with competitors

Y-Mabs Therapeutics (YMAB) profit margin is -16.60%.

TickerNameProfit MarginUpside
OMEROmeros Corporation871.00%-5347.51%
PRTCPureTech Health plc American Depositary Shares793.00%-4877.58%
ABEOAbeona Therapeutics Inc454.90%-2840.63%
CHRSCoherus Biosciences Inc397.30%-2493.61%
FBIOFortress Biotech Inc193.10%-1263.37%
INVAInnoviva Inc119.90%-822.36%
ZVRAZevra Therapeutics Inc101.60%-712.11%
ABUSArbutus Biopharma Corp94.73%-670.72%
SAVACassava Sciences Inc.93.68%-664.39%
GLPGGalapagos NV86.83%-623.12%
CTNMContineum Therapeutics Inc - Class A83.13%-600.83%
BDTXBlack Diamond Therapeutics Inc80.77%-586.61%
NEUPNeuphoria Therapeutics Inc75.08%-552.33%
IPSCCentury Therapeutics Inc70.13%-522.51%
FULCFulcrum Therapeutics Inc69.26%-517.27%
CVACCureVac N.V.68.44%-512.33%
PRTAProthena Corporation plc64.05%-485.88%
QTTBQ32 Bio Inc61.90%-472.93%
AVIRAtea Pharmaceuticals Inc60.95%-467.20%
ASNDAscendis Pharma A/S57.30%-445.21%
PLXProtalix BioTherapeutics Inc54.27%-426.96%
HCWBHCW Biologics Inc53.42%-421.84%
AGENAgenus Inc52.20%-414.49%
CGENCompugen Ltd48.57%-392.62%
KRYSKrystal Biotech Inc48.07%-389.61%
RPRXRoyalty Pharma plc - Class A46.73%-381.53%
XOMAPXOMA Royalty Corp45.90%-376.53%
XOMAOXOMA Royalty Corp45.90%-376.53%
AUPHAurinia Pharmaceuticals Inc44.21%-366.35%
NXTCNextcure Inc43.49%-362.01%
CPRXCatalyst Pharmaceuticals Inc42.66%-357.01%
HALOHalozyme Therapeutics Inc39.83%-339.96%
ADMAAdma Biologics Inc39.59%-338.52%
XOMAXOMA Royalty Corp36.25%-318.40%
VRTXVertex Pharmaceuticals Inc34.53%-308.03%
EXELExelixis Inc34.46%-307.61%
SLNOSoleno Therapeutics Inc33.17%-299.84%
CRMDCorMedix Inc30.29%-282.49%
TNGXTango Therapeutics Inc29.52%-277.85%
ARGXArgen X SE28.20%-269.90%
CAICaris Life Sciences Inc - Class A27.98%-268.57%
JAZZJazz Pharmaceuticals plc27.42%-265.20%
SPROSpero Therapeutics Inc24.90%-250.01%
INCYIncyte Corp23.83%-243.57%
REGNRegeneron Pharmaceuticals Inc20.17%-221.52%
NAGENiagen Bioscience Inc20.07%-220.92%
ICCCImmucell Corp18.75%-212.96%
NERVMinerva Neurosciences Inc17.79%-207.18%
ALNYAlnylam Pharmaceuticals Inc16.99%-202.36%
ENVBEnveric Biosciences Inc16.64%-200.25%
TECHBio-Techne Corp16.39%-198.74%
HRMYHarmony Biosciences Holdings Inc15.08%-190.85%
ONCBeiGene Ltd15.02%-190.49%
RIGLRigel Pharmaceuticals14.71%-188.62%
BMRNBiomarin Pharmaceutical Inc13.77%-182.96%
VXRTVaxart Inc13.20%-179.53%
IMCRImmunocore Holdings plc12.16%-173.26%
VRNAVerona Pharma Plc11.56%-169.65%
TGTXTG Therapeutics Inc9.65%-158.14%
APLSApellis Pharmaceuticals Inc6.95%-141.87%
PTGXProtagonist Therapeutics Inc6.71%-140.43%
NUVBNuvation Bio Inc - Class A6.48%-139.04%
FBIOPFortress Biotech Inc6.40%-138.56%
GMABGenmab5.92%-135.67%
SRPTSarepta Therapeutics Inc2.98%-117.95%
BMEABiomea Fusion Inc2.37%-114.28%
ACADAcadia Pharmaceuticals Inc1.36%-108.19%
FENCFennec Pharmaceuticals Inc1.33%-108.01%
FOLDAmicus Therapeutics Inc0.91%-105.48%
HOTHHoth Therapeutics Inc0.17%-101.02%
BBLGBone Biologics Corp0.02%-100.12%